Skip to content

Prevention of recurrent severe hypoglycaemia: optimised multiple daily insulin injection (MDI) versus continuous subcutaneous insulin infusion (CSII) with or without adjunctive real-time continuous glucose monitoring

A definitive randomised controlled trial (RCT) comparing optimised multiple daily insulin injection (MDI) and continuous subcutaneous insulin infusion (CSII) with or without adjunctive real-time continuous glucose monitoring for the prevention of recurrent severe hypoglycaemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52164803
Enrollment
100
Registered
2009-09-18
Start date
2010-01-01
Completion date
Unknown
Last updated
2023-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes mellitus Nutritional, Metabolic, Endocrine Insulin-dependent diabetes mellitus

Interventions

All participants will participate in an educational programme which has been validated in our single centre pilot study. This includes carbohydrate counting, discussion on glycaemic indices of food, t

Sponsors

Newcastle Upon Tyne Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female patients aged 18 - 74 years 2. Established type 1 diabetes mellitus (C peptide negative) 3. Experienced impaired hypoglycaemia awareness and, or at least one episode of severe hypoglycaemia as defined as by the American Diabetes Association in the previous 12 months 4. Willing to undergo intensive insulin therapy including the use of CSII (insulin pump) 5. Willing to monitor home blood glucose levels at least four times daily 6. Willing to monitor and record signs and symptoms of hypoglycaemia

Exclusion criteria

Exclusion criteria: 1. Not willing to consider insulin pump therapy 2. Unable to use the technology such as real time glucose monitoring

Design outcomes

Primary

MeasureTime frame
Restoration of hypoglycaemia awareness as determined by quantitative questionnaire analysis.

Secondary

MeasureTime frame
1. Difference in rates of mild symptomatic hypoglycaemia as measured by home blood glucose diaries at 6 months and intermediate study visits 2. Difference in duration of biochemical hypoglycaemia determined by 7-day continuous glucose monitoring system (CGMS) at 6 months and intermediate study visits 3. Difference in HbA1c at 6 months and intermediate study visits 4. Difference in rates weekly 8-point glucose profiles

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 24, 2026